Efficacy and Safety of Histamine H3 Receptor Antagonist/Inverse Agonist Including Betahistine for Schizophrenia: A Systematic Review and Meta‐Analysis

Documenti analoghi

• Letter to the Editor in Response to “Efficacy and Safety of Histamine H3 Receptor Antagonist/Inverse Agonist Including Betahistine for Schizophrenia: A Systematic Review and Meta‐Analysis” by Nishii et al.
  di: Muhammad Farhan
  Pubblicazione: (2025)
• Physical, Mental, and Social Characteristics Associated With Happiness in Individuals With Schizophrenia in Japan: A Cross‐Sectional Study
  di: Junna Hattori, et al.
  Pubblicazione: (2025)
• Effects of Histamine H 3 Receptor Antagonist/Inverse Agonist Pitolisant on Temporal Prediction, Spatial Switching, and Spontaneous Locomotion in Mice
  di: Shohei Kaneko, et al.
  Pubblicazione: (2026)
• Comparison of brexpiprazole, aripiprazole, and placebo for Japanese major depressive disorder: A systematic review and network meta‐analysis
  di: Taro Kishi, et al.
  Pubblicazione: (2024)
• Post‐marketing surveillance of quetiapine fumarate extended‐release tablets in patients with bipolar depression
  di: Taro Kishi, et al.
  Pubblicazione: (2024)